A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis

被引：0
|
作者：
Rao, Shiavax J. [1 ]
Kumar, Kaushik [1 ]
Saleh, Nahar [1 ]
机构：
[1] MedStar Union Mem Hosp, Internal Med, Baltimore, MD 21218 USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 10期
关键词：
high anion gap metabolic acidosis; sglt-2; inhibitor; euglycemic dka; diabetic keto acidosis; sodium-glucose cotransporter-2 inhibitors;
D O I：
10.7759/cureus.30106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
While rare, serious adverse effects including euglycemic diabetic ketoacidosis (EDKA) have been associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. We present an interesting case of SGLT2i-induced EDKA occurring two years after initiation of therapy. Most patients with EDKA recover with prompt recognition and treatment. Patient education about identifying early signs remains a cornerstone of early identification and response to SGLT2i-induced EDKA.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] SGLT2 INHIBITOR-INDUCED EUGLYCEMIC DIABETIC KETOACIDOSIS
    Chawla, Ambreesh
    Healy, Austin
    Kim, Minha
    Sapru, Sunil
    CHEST, 2018, 154 (04) : 363A - 363A
  • [2] SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report
    Wang, Katherine M.
    Isom, Robert T.
    KIDNEY MEDICINE, 2020, 2 (02) : 218 - 221
  • [3] SGLT2 Inhibitor-Induced Euglycemic Ketoacidosis in a Non-Diabetic Patient with Ischemic Cardiomyopathy
    Khadka, Sulochana
    Rajak, Kripa
    Matai, Pallavi
    Timilsina, Bibek
    Sharma, Seema
    Halder, Anupam
    Martinez, Evelyn Calderon
    Jaiswal, Vikash
    CIRCULATION, 2024, 150
  • [4] SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors
    Solinsky, Paul Joseph
    Holstege, Amy
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [5] SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis
    Anis, K.
    Eldib, A.
    Mitri, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
    Alhemeiri, Mohamed
    Alseddeeqi, Eiman
    CASE REPORTS IN ENDOCRINOLOGY, 2022, 2022
  • [7] Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report
    Klinkner, Gwen
    Steingraber-Pharr, Maggie
    AACN ADVANCED CRITICAL CARE, 2023, 34 (01) : 27 - 32
  • [8] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [9] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Zohaib Yousaf
    Fateen Ata
    Adeel Ahmad Khan
    Almurtada Razok
    Jaweria Akram
    Elrazi Awadelkarim Hamid Ali
    Ahmed Abdalhadi
    Mohammed I. Danjuma
    Dabia Hamad S. H. Al Mohanadi
    European Journal of Clinical Pharmacology, 2021, 77 : 1431 - 1433
  • [10] EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT ON SGLT2 INHIBITOR THERAPY: A CASE REPORT AND PATHOPHYSIOLOGICAL INSIGHTS
    Jensen, Colton
    Cervantes, C. Elena
    Hanouneh, Mohamad
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04) : S42 - S43
12345